Abstract
An ethanol extract of Helichrysum maracandicum showed antiproliferative activity against cultured cells of SENCAR mouse in an in vitro assay, and activity-guided fractionation of the extract resulted in the isolation of isosalipurposide as an active substance. Naringenin chalcone, the aglycone of isosalipurposide, also showed strong antiproliferative activity. An in vivo assay of two-stage carcinogenesis on mouse skin revealed that epidermal application of isosalipurposide resulted in delayed formation of papillomas. Western blot analysis showed that the expression of p38 mitogen-activated protein kinase was suppressed by the administration of naringenin chalcone or isosalipurposide, which might be related to the anticarcinogenic activity.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Carcinogenic processes include two or more stages such as initiation and promotion. Prevention of the promotion stage has been a major target for the investigation on anticarcinogenic natural products [1], and an in vivo two-stage carcinogenesis test using the SENCAR mouse had been established as a model screening system; the assay starts with treatment of SENCAR mouse skin with 12-dimethylbenz[a]anthracene (DMBA) as an initiator followed by promoter treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) after a specific period of time [2]. In the process of carcinogenesis, it is known that some genes of growth-related signal transduction pathways are activated and some others are silenced. In particular, transcription factors such as activator protein 1 (AP1) and nuclear factor kappa B (NFκB) are involved in MAP kinase signaling pathways and are activated by tumor promoters [3].
In our in vitro screening of medicinal plants collected in Uzbekistan for antiproliferative activity against SENCAR mouse skin transformed cells (SST cell) and SENCAR mouse skin transformed tumor cells (SST-T cell), an extract of Helichrysum maracandicum, one of the original plants of a folk medicine helichrysum, showed strong activity and was studied for its active compound.
Helichrysum (Helichrysum sp., Compositae) is a common folk medicine for gall bladder disorders [4, 5] from Turkey to Central Asia. Extracts of helichrysum were reported to contain flavonoids, phloroglucinol derivatives and diterpenes [4, 6–8] and to show choleretic [5], antimicrobial [9], antioxidative [10], antiinflammatory [11], diuretic and antihypertensive activities [12]. In this report, we show that a chalcone glycoside derived from H. maracandicum, as well as its aglycone, showed the antiproliferative activity.
Materials and methods
Plant materials
Aerial parts of Allium motor R. KAM. et LEVICHEV (Liliaceae) (no. ESM-C03051), leaves of Betula tianschanica RUPR. (Betulaceae) (no. ESM-C03054), whole plant of Dracocephalum komarovi LIPSKY (Labiatae) (no. ESM-C03055 and ESM-C03056), flowers of H. maracandicum M. POP. ex KIRP. (Compositae) (no. ESM-C03052), aerial parts of Paeonia hybrida PALL. (Paeoniaceae) (no. ESM-C03053) and fruits of Rhamnus cathartica L. (Rhamnaceae) (no. ESM-03057) were collected in Uzbekistan in 2003. Voucher specimens are deposited at the Graduate School of Pharmaceutical Sciences, Kyoto University. The ethanol extracts of these plants were used in the in vitro bioassay described below.
Cell culture and short-term in vitro bioassay for cell proliferation
SENCAR mouse skin transformed (SST) cells are a cultured cell line of normal skin epithelium cells of SENCAR mouse. SENCAR mouse skin transformed tumor (SST-T) cells are a cell line made by applying peroxynitrite [13] to SST cells. The cells were incubated in 4-cm diameter dishes (approx. 5 × 105 cells/dish) in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) at 35°C in an atmosphere of 5% CO2/95% air. Plant extracts dissolved in 10 μl dimethylsulfoxide (DMSO) were added to the dishes. Ten microliters of DMSO and quercetin dissolved in DMSO were used as negative and positive controls, respectively. Cells were observed under a microscope 24 h after the sample addition, and the number of viable cells determined by a trypan blue exclusion test was counted with a cytometer.
Two-stage mouse skin carcinogenesis test
Fifteen SENCAR mice (female, 6 weeks old) were used for each test compound. Mice were housed in a polycarbonate cage in an SPF room with free access to food and water throughout the experiment. Back skin of the mouse was shaved 1 day before DMBA treatment, and 100 μg of DMBA (390 nmol) in 100 μl acetone was applied topically to the shaved back as an initiator. One week after the initiation treatment, a sample solution (50 μg/100 μl acetone) was applied to the initiated area, which was followed by an administration of TPA (1 μg, 1.7 nmol) in 100 μl acetone an hour later as a promoter treatment. Thereafter, a set of sample and TPA treatments was repeated twice a week for 20 weeks. The number of papillomas was counted weekly for 20 weeks. All animal experiments were performed according to the guidelines for animal experimentations of Kyoto Prefectural University of Medicine.
Isolation of isosalipurposide (1) and preparation of naringenin chalcone (2)
Flowers of H. maracandicum (1.4 kg) were extracted with ethanol overnight at room temperature three times to give an ethanol extract (111 g). Ten grams of the extract was dissolved in 30% MeOH in water and was extracted sequentially with hexane and then AcOEt to give hexane-soluble (1.2 g) and AcOEt-soluble (4.3 g) fractions. The aqueous layer was concentrated to dryness to give a water-soluble fraction (3.0 g). The AcOEt-soluble fraction was subjected to silica gel column chromatography with CHCl3–MeOH (4:1) to give three fractions, fr-1 (0.56 g), fr-2 (2.99 g) and fr-3 (0.31 g). Three hundred milligrams of fr-2 was further fractionated by column chromatography with the same conditions as above to afford isosalipurposide (1) (11 mg). The compound was identified by comparing NMR data with those previously reported [14] and measuring HMQC and HMBC spectra. Naringenin chalcone (2) was prepared from naringenin according to the method of Le Bail [15].
Western blot analysis
Cultured cells were washed with phosphate-buffered saline (PBS) and then lysed and homogenized in CelLytic M cell lysis buffer (Sigma). Mouse skin epithelia were collected under ice-cold conditions 1–10 days after applying 1 mg of sample in 100 μl acetone to partially shaved back skin of SENCAR mouse and homogenized in CelLytic MT cell lysis buffer. Cytosolic fractions of the cultured cells and the epithelial cells were collected as the supernatant after centrifugation at 10,000 g for 5 min at 4°C. SDS-PAGE was performed on 4–20% gradient polyacrylamide gels and aliquots of the cytosolic fractions diluted with lysis buffer were loaded. Separated proteins were transferred to Immobilon transfer membranes (Millipore). After blocking with 5% low fat milk in PBS, membranes were incubated for 1–3 days at 4°C in PBS containing 3% bovine serum albumin (BSA) and H-Ras, Raf-1, MEK-2 or p38 MAP kinase antibodies (Santa Cruz), followed by 30–40 min incubation with peroxidase-labeled second antibodies (Amersham). The signals were detected using ECL Chemi-Lumi One (Nacalai Tesque) according to the manufacturer’s instructions.
Results and discussion
Ethanol extracts of six species of medicinal plants collected in Uzbekistan were tested for inhibitory activity against cell proliferation (Table 1). The extract of H. maracandicum was found to be the most effective among them especially on SST cells. The stronger activity of the extract on SST cells compared to SST-T cells might suggest that its activity was anticarcinogenic rather than antitumoral. Fractionation of the ethanol extract into hexane-, AcOEt- and water-soluble portions revealed that the activity was soluble in organic solvents. Treatment of SST cells with the hexane-soluble fraction caused vacuolization and swelling of the cytoplasm, whereas treatment with the ethanol extract caused nucleic and cytoplasmic metamorphosis (Fig. 1). The hexane-soluble fraction was separated by column chromatography into several fractions; however, every fraction showed similar activity. This suggests that necrosis-like cellular vacuolization was due to compounds commonly distributed among the separated fractions. Antiproliferation activity-guided fractionation of the AcOEt-soluble fraction resulted in isolation of a chalcone glycoside, isosalipurposide (1), as an active compound. Generally, glycosides are hydrolyzed into aglycones and sugars in the gastrointestinal tract after oral administration. Naringenin chalcone (2), the aglycone of 1, was prepared. Both 1 and 2 showed stronger inhibitory effects than quercetin [16] to SST cells (Table 1).
In vivo activity of the fractions and compounds was examined using a two-stage mouse skin carcinogenesis test. Papillomas were observed on all mice in the control group 10 weeks after TPA treatment (Fig. 2a). Administration of the ethanol extract, 1 or 2, reduced the percentage of mice with papillomas to 0, 20 and 11% at 10 weeks and 60, 80 and 67% at 20 weeks, respectively. Anticarcinogenic activity was also demonstrated by counting the number of papilloma per mouse (Fig. 2b). At 20 weeks, the average numbers of papillomas per mouse treated with the ethanol extract, 1 or 2 were less than that of the control group at 11, 44 and 22%, respectively. However, the hexane-soluble fraction showed no anticarcinogenic activity.
In order to understand the mechanism of their tumor preventive activity, the expression of some proteins related to the MAP kinase pathway was analyzed. The MAP kinase pathway is suggested to be involved in carcinogenesis [3], and its related proteins, namely, H-Ras, Raf-1, MEK-2 and p38 MAP kinase, were observed for their expression in SST and SST-T cells treated with the ethanol extract of H. maracandicum. It was found that p38 MAP kinase was suppressed in a time-dependent manner in SST cells, but not in SST-T cells (Fig. 3a). Expression of the kinase was also suppressed by the ethanol extract, 1 and 2 in two-stage mouse skin carcinogenesis tests, but not by the hexane-soluble fraction (Fig. 3b). These results were consistent with the antiproliferative activity on SST cells and the decrease in the percentage of mice with papillomas and average number of papillomas per mouse, suggesting that the suppression of p38 MAP kinase expression was involved in the prevention of tumorigenesis.
The present study elucidated that compound 1 is the active anticarcinogenic component in the ethanol extract of H. maracandicum. Compound 2, the aglycone of 1, was also shown to be an effective compound; however, the efficacy of these isolated compounds (50 μg) was less than that of the original ethanol extract (50 μg) in two-stage mouse skin carcinogenesis tests. There may be other potent components and/or synergistic effect among constituents in the extract.
Compounds 1 and 2 were reported to have antioxidative activity [17, 18]. Antioxidation would play a key role in the prevention of cancers, since reactive oxygen species cause cell damage, which can be followed by carcinogenesis. Antioxidants have been shown to attenuate MAP kinase signals [19, 20], and the ethanol extract of H. maracandicum as well as compounds 1 and 2 were shown to suppress the expression of p38 MAP kinase. Inhibition of p38 MAP kinase is known to reduce cyclooxygenase-2 (COX-2) gene expression [21], and inhibition of COX-2 is assumed to be important in cancer prevention [21, 22] as well as in antiinflammation. These factors may be involved with the anticarcinogenic effect of the ethanol extract and compounds 1 and 2.
In this study, we revealed the anticarcinogenic compounds of H. maracandicum, one of the original plants of helichrysum that have been used across a wide region of Eurasia as a common tea herb for cholagogue [4, 5]. Traditional folk medicines have high potential as resources in the development of new drugs. Modern scientific techniques can clarify the active components of folk medicines and give explanations for their usefulness, although the active compounds may not have novel structures. We hope our results here can serve as an example of these cases.
References
Murakami A, Ohigashi H, Koshimizu K (1996) Anti-tumor promotion with food phytochemicals: a strategy for cancer chemoprevention. Biosci Biotechnol Biochem 60:1–8
Digiovanni J (1992) Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63–128
Bode AM, Dong Z (2000) Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 1:181–188
Suzgec S, Mericli AH, Houghton PJ, Cubukcu B (2005) Flavonoids of Helichrysum compactum and their antioxidant and antibacterial activity. Fitoterapia 76:269–272
Delapuerta R, Saenz MT, Garcia MD (1993) Choleretic effect of the essential oil from Helichrysum picardii Boiss and Reuter in rats. Phytother Res 7:376–377
Drewes SE, Mudau KE, Van Vuuren SF, Viljoen AM (2006) Antimicrobial monomeric and dimeric diterpenes from the leaves of Helichrysum tenax var tenax. Phytochemistry 67:716–722
Jakupovic J, Kuhnke J, Schuster A, Metwally MA, Bohlmann F (1986) Phloroglucinol derivatives and other constituents from South African Helichrysum species. Phytochemistry 25:1133–1142
Randriaminahy M, Proksch P, Witte L, Wray V (1992) Lipophilic phenolic constituents from Helichrysum species endemic to Madagascar. Z Naturforsch C 47:10–16
Meyer JJM, Afolayan AJ (1995) Antibacterial activity of Helichrysum aureonitens (Asteraceae). J Ethnopharmacol 47:109–111
Tepe B, Sokmen M, Akpulat HA, Sokmen A (2005) In vitro antioxidant activities of the methanol extracts of four Helichrysum species from Turkey. Food Chem 90:685–689
Jager AK, Hutchings A, vanStaden J (1996) Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors. J Ethnopharmacol 52:95–100
Musabayane CT, Munjeri O, Mdege ND (2003) Effects of Helichrysum ceres extracts on renal function and blood pressure in the rat. Ren Fail 25:5–14
Tokuda H, Ichiishi E, Onozuka M, Yamaguchi S, Konoshima T, Takasaki M, Nishino H (1998) The tumor initiating activity of NO donor. In: Moncada S, Tada N, Maeda H (eds) Biology of nitric oxide, part 6. Portland Press, London, pp 185–186
Zapesochnaya GG, Kurkin VA, Braslavskii VB, Filatova NV (2002) Phenolic compounds of Salix acutifolia bark. Chem Nat Comp 38:314–318
Le Bail JC, Pouget C, Fagnere C, Basly JP, Chulia AJ, Habrioux G (2001) Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities. Life Sci 68:751–761
Kato R, Nakadate T, Yamamoto S, Sugimura T (1983) Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4:1301–1305
Facino RM, Carini M, Franzoi L, Pirola O, Bosisio E (1990) Phytochemical characterization and radical scavenger activity of flavonoids from Helichrysum italicum G. Don (Compositae). Pharmacol Res 22:709–721
Calliste CA, Le Bail JC, Trouillas P, Pouget C, Habrioux G, Chulia AJ, Duroux JL (2001) Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res 21:3949–3956
Mantena SK, Katiyar SK (2006) Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-κB signaling in human epidermal keratinocytes. Free Radic Biol Med 40:1603–1614
Katiyar SK, Afaq F, Azizuddin K, Mukhtar H (2001) Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (−)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 176:110–117
Chen WX, Tang QB, Gonzales MS, Bowden GT (2001) Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 20:3921–3926
Subbaramaiah K, Dannenberg AJ (2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24:96–102
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yagura, T., Motomiya, T., Ito, M. et al. Anticarcinogenic compounds in the Uzbek medicinal plant, Helichrysum maracandicum . J Nat Med 62, 174–178 (2008). https://doi.org/10.1007/s11418-007-0223-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-007-0223-y